Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 22, 2014
- Accepted for publication April 28, 2014
- Published online August 1, 2014.
Article Versions
- previous version (June 12, 2014 - 05:25).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- John P. Seibyl*,1,
- Andreas Kupsch2,
- Jan Booij3,
- Donald G. Grosset4,
- Durval C. Costa5,
- Robert A. Hauser6,
- Jacques Darcourt7,
- Nin Bajaj8,
- Zuzana Walker9,10,
- Kenneth Marek1,
- Ian McKeith11,
- John T. O’Brien12,
- Klaus Tatsch13,
- Eduardo Tolosa14,
- Rudi A. Dierckx15 and
- Igor D. Grachev*,16
- 1Institute for Neurodegenerative Disorders, New Haven, Connecticut
- 2Department of Neurology and Stereotactic Neurosurgery, Otto-von-Guericke-University, Magdeburg, Germany
- 3Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- 4Institute of Neurological Sciences, Southern General Hospital and University of Glasgow, Glasgow, Scotland
- 5Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal
- 6Departments of Neurology, Molecular Pharmacology and Physiology, USF Health Byrd Parkinson’s Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, Tampa, Florida
- 7Department of Nuclear Medicine, Centre Antoine Lacassagne, TIRO Research Group, University of Nice Sophia-Antipolis, Nice, France
- 8Department of Clinical Neurology, National Parkinson's Foundation International Centre of Excellence, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre Campus, Nottingham, United Kingdom
- 9Division of Psychiatry, University College London, London, United Kingdom
- 10North Essex Partnership University NHS Foundation Trust, Essex, United Kingdom
- 11Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom
- 12Department of Psychiatry, University of Cambridge School of Clinical Medicine and Cambridgeshire and Peterborough Foundation NHS Trust, Cambridge, United Kingdom
- 13Department of Nuclear Medicine, Municipal Hospital Karlsruhe, Inc., Karlsruhe, Germany
- 14Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Catalonia, Spain
- 15Departments of Radiology, Nuclear Medicine, and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands; and
- 16Medical Affairs, Life Sciences, GE Healthcare, Princeton, New Jersey
- For correspondence or reprints contact: John Seibyl, Institute for Neurodegenerative Disorders, 60 Temple St., 8A, New Haven, CT 06510. E-mail: jseibyl{at}mnimaging.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Determining the Degree of Dopaminergic Denervation Based on the Loss of Nigral Hyperintensity on SMWI in Parkinsonism
- The Future of Nuclear Medicine as an Independent Specialty
- Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia